Your session is about to expire
← Back to Search
Breathing Exercise Training for Rapid Heartbeat
N/A
Waitlist Available
Led By Thomas Chelimsky, M.D.
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline.
Awards & highlights
Study Summary
This trial studies the effects of breathing exercises on Postural tachycardia syndrome (POTS). Results may help doctors understand how the brain works.
Who is the study for?
This trial is for English-speaking adults aged 18-50 with Postural Orthostatic Tachycardia Syndrome (POTS). It's not suitable for those with chronic neurological conditions other than POTS, inflammatory arthritis, autoimmune disorders, or unstable medical issues like severe kidney or liver problems and poorly controlled heart disease.Check my eligibility
What is being tested?
The study tests if breathing exercise training can improve brain communication in people with POTS. Participants will practice these exercises to see their effect on the condition and brain function related to the periaqueductal gray area.See study design
What are the potential side effects?
Breathing exercises are generally safe but may cause temporary discomfort such as dizziness or shortness of breath. Long-term side effects are unlikely but participants will be monitored for any unexpected reactions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Body Weight Changes
Change in PAG activation - resting
Polyacrylamide Gel Electrophoresis
Secondary outcome measures
Change in Fatigue Severity Scale (FSS) score from baseline
Change in Generalized Anxiety Disorder Scale (GAD-2) score from baseline
Change in PROMIS Physical Function (PROMIS 8b) from baseline
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: TrainingExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
697 Previous Clinical Trials
22,884,984 Total Patients Enrolled
1 Trials studying Postural Orthostatic Tachycardia Syndrome
36 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Thomas Chelimsky, M.D.Principal InvestigatorVirginia Commonwealth University
1 Previous Clinical Trials
1,188 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not using hormones, except for insulin, thyroid replacements, or birth control.I have a nerve or brain disorder like MS, stroke, or cerebral palsy.I have been taught breathing exercises in a clinic visit.I am between 18 and 50 years old.I have a chronic neurological condition other than POTS or syncope-related issues.I have an appointment at the VCU Autonomics Center in at least a week.I have an inflammatory, connective tissue, or autoimmune condition.I have been diagnosed with POTS or experience fainting or near-fainting.I haven't used any unapproved drugs or devices in the last 30 days.I haven't had major surgery in the last 60 days or minor procedures in the last 7 days.I do not have any uncontrolled major health issues like kidney, liver, heart problems, severe diabetes, thyroid issues, or untreated mental health conditions.
Research Study Groups:
This trial has the following groups:- Group 1: Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research accessible to those under the age of fifty?
"The target demographic for this study consists of adults between the ages 18 and 50."
Answered by AI
What is the upper limit on participants for this clinical investigation?
"Affirmative. The clinical trial is actively recruiting, as indicated by the information on clinicaltrials.gov which was published on December 1st 2022 and last updated November 9th 2022. A total of 12 patients are needed to be recruited from a single site."
Answered by AI
What are the eligibility criteria for participating in this clinical research?
"This clinical trial seeks 12 participants who have been diagnosed with marijuana abuse, between 18 and 50 years of age."
Answered by AI
Is there availability for subjects to join this research endeavor?
"According to current information found on clinicaltrials.gov, this medical trial is recruiting participants. It was initially established on the 1st of December 2022 and has recently been updated on November 9th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger